Pregabalin in the management of partial epilepsy

References

• SanderJWShorvonSDEpidemiology of the epilepsiesJ Neurol Neurosurg Psychiatry19966154334438965090
   PubMed Web of Science ®Google Scholar
• ArainAMedical therapy of epilepsyExpert Opin Ther Pat2007178955964
   Web of Science ®Google Scholar
• KwanPBrodieMJEarly identification of refractory epilepsyN Engl J Med2000342531431910660394
   PubMed Web of Science ®Google Scholar
• MarsonAGKadirZAChadwickDWNew antiepileptic drugs: a systematic review of their efficacy and tolerabilityBMJ19963137066116911748916746
   PubMed Web of Science ®Google Scholar
• VartanianMGRadulovicLLKinsoraJJActivity profile of pregabalin in rodent models of epilepsy and ataxiaEpilepsy Res200668318920516337109
   PubMed Web of Science ®Google Scholar
• TaylorCPAngelottiTFaumanEPharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discoveryEpilepsy Res200773213715017126531
   PubMed Web of Science ®Google Scholar
• DooleyDJDonovanCMMederWPWhetzelSZPreferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slicesSynapse200245317119012112396
   PubMed Web of Science ®Google Scholar
• PatsalosPNPeruccaEClinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugsLancet Neurol20032847348112878435
   PubMed Web of Science ®Google Scholar
• HardenCLLeppikIOptimizing therapy of seizures in women who use oral contraceptivesNeurology20066712 Suppl 4S56S5817190925
   PubMed Web of Science ®Google Scholar
• PeruccaEClinically relevant drug interactions with antiepileptic drugsBr J Clin Pharmacol200661324625516487217
   PubMed Web of Science ®Google Scholar
• BrodieMJWilsonEAWescheDLPregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsyEpilepsia20054691407141316146435
   PubMed Web of Science ®Google Scholar
• MayTWRambeckBNebRJurgensUSerum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedicationTher Drug Monit200729678979418043477
   PubMed Web of Science ®Google Scholar
• JohannessenSITomsonTPharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?Clin Pharmacokinet200645111061107517048972
   PubMed Web of Science ®Google Scholar
• RandinitisEJPosvarELAlveyCWSedmanAJCookJABockbraderHNPharmacokinetics of pregabalin in subjects with various degrees of renal functionJ Clin Pharmacol200343327728312638396
   PubMed Web of Science ®Google Scholar
• FrenchJAKuglerARRobbinsJLKnappLEGarofaloEADose-response trial of pregabalin adjunctive therapy in patients with partial seizuresNeurology200360101631163712771254
   PubMed Web of Science ®Google Scholar
• ArroyoSAnhutHKuglerARPregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizuresEpilepsia2004451202714692903
   PubMed Web of Science ®Google Scholar
• BeydounAUthmanBMKuglerARGreinerMJKnappLEGarofaloEASafety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsyNeurology200564347548015699378
   PubMed Web of Science ®Google Scholar
• ElgerCEBrodieMJAnhutHLeeCMBarrettJAPregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled studyEpilepsia200546121926193616393158
   PubMed Web of Science ®Google Scholar
• LozsadiDHemmingKMarsonAGPregabalin add-on for drug-resistant partial epilepsyCochrane Database Syst Rev20081CD00561218254084
   PubMed Web of Science ®Google Scholar
• RyvlinPPeruccaERheimsSPregabalin for the management of partial epilepsyNeuropsychiatr Dis Treat2008461211122419337461
   PubMedGoogle Scholar
• WarnerGFiggittDPPregabalin: as adjunctive treatment of partial seizuresCNS Drugs2005193265272 discussion 273–264.15740180
   PubMed Web of Science ®Google Scholar
• BrodieMJPregabalin as adjunctive therapy for partial seizuresEpilepsia200445 Suppl 6192715315512
   PubMed Web of Science ®Google Scholar
• Vera-LlonchMBrandenburgNAOsterGCost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsyEpilepsia200849343143717822431
   PubMed Web of Science ®Google Scholar
• Gil-NagelAZaccaraGBaldinettiFLeonTAdd-on treatment with pregabalin for partial seizures with or without generalisation: Pooled data analysis of four randomised placebo-controlled trialsSeizure200918318419218951818
   PubMed Web of Science ®Google Scholar
• HoppeCRademacherMHoffmannJMSchmidtDElgerCEBodyweight gain under pregabalin therapy in epilepsy: mitigation by counseling patients?Seizure200817432733218060813
   PubMed Web of Science ®Google Scholar
• ArainAShihabuddinBNiazFEpilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional settingEpilepsia200647122052205717201703
   PubMed Web of Science ®Google Scholar
• ModurPNMilteerWEAdjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsyEpilepsy Behav200813355455618579443
   PubMed Web of Science ®Google Scholar
• HuberBBocchicchioMFeuerbaumEEfficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disabilityEpilepsy Behav200813239740118554985
   PubMed Web of Science ®Google Scholar
• SeeleyJMMrelashviliDGallagherMJArainAAbou-KhalilBPregabalin efficacy and tolerability in patients with intractable partial seizures. A postmarketing analysisEpilepsia200748s6320321
   Google Scholar
• KubotaTFangJMeltzerLTKruegerJMPregabalin enhances nonrapid eye movement sleepJ Pharmacol Exp Ther200129931095110511714899
   PubMed Web of Science ®Google Scholar
• RomigiAIzziFMarcianiMGPregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic studyEur J Neurol2009161707519087152
   PubMed Web of Science ®Google Scholar
• Johannessen Landmark CAntiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacyCNS Drugs2008221274718072813
   PubMed Web of Science ®Google Scholar
• LesserHSharmaULaMoreauxLPooleRMPregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trialNeurology200463112104211015596757
   PubMed Web of Science ®Google Scholar
• DworkinRHCorbinAEYoungJPJrPregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trialNeurology20036081274128312707429
   PubMed Web of Science ®Google Scholar
• MeasePJRussellIJArnoldLMA randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgiaJ Rheumatol200835350251418278830
   PubMed Web of Science ®Google Scholar
• MontgomerySATobiasKZornbergGLKasperSPandeACEfficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxineJ Clin Psychiatry200667577178216841627
   PubMed Web of Science ®Google Scholar
• HuppertzHJFeuersteinTJSchulze-BonhageAMyoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalinEpilepsia200142679079211422338
   PubMed Web of Science ®Google Scholar
• BeydounANasreddineWAtwehSEfficacy and tolerability of pregabalin in partial epilepsyExpert Rev Neurother2008871013102418590472
   PubMedGoogle Scholar
• MensahSABeavisJMThaparAKKerrMPA community study of the presence of anxiety disorder in people with epilepsyEpilepsy Behav200711111812417532266
   PubMed Web of Science ®Google Scholar